Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation

Daily Values

Growth Metrics

Others

Ratios

Jefferson Capital (JCAP) Asset Writedowns and Impairment (2024 - 2025)

Jefferson Capital (JCAP) has disclosed Asset Writedowns and Impairment for 2 consecutive years, with $690000.0 as the latest value for Q4 2025.

Quarterly Asset Writedowns and Impairment fell 19.77% to $690000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $2.4 million for FY2025, 32.51% down from the prior year.
Asset Writedowns and Impairment for Q4 2025 was $690000.0 at Jefferson Capital, up from $569000.0 in the prior quarter.
The five-year high for Asset Writedowns and Impairment was $867000.0 in Q3 2024, with the low at $569000.0 in Q3 2025.